CH483417A - Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B, 10x-steroids - Google Patents

Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B, 10x-steroids

Info

Publication number
CH483417A
CH483417A CH553869A CH553869A CH483417A CH 483417 A CH483417 A CH 483417A CH 553869 A CH553869 A CH 553869A CH 553869 A CH553869 A CH 553869A CH 483417 A CH483417 A CH 483417A
Authority
CH
Switzerland
Prior art keywords
bisdehydro
keto
steroid
preparation
Prior art date
Application number
CH553869A
Other languages
English (en)
Inventor
Reinder Rix Theodorus
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL63301566A external-priority patent/NL146503B/xx
Application filed by Philips Nv filed Critical Philips Nv
Publication of CH483417A publication Critical patent/CH483417A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
CH553869A 1963-12-09 1964-12-07 Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B, 10x-steroids CH483417A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL63301566A NL146503B (nl) 1963-12-09 1963-12-09 Werkwijze voor de bereiding van een 9beta, 10alfa-pregna-4,6-dieen-3,20-dion.
CH1586264A CH491898A (de) 1963-12-09 1964-12-07 Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B,10a-steroids

Publications (1)

Publication Number Publication Date
CH483417A true CH483417A (de) 1969-12-31

Family

ID=25717126

Family Applications (1)

Application Number Title Priority Date Filing Date
CH553869A CH483417A (de) 1963-12-09 1964-12-07 Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B, 10x-steroids

Country Status (1)

Country Link
CH (1) CH483417A (de)

Similar Documents

Publication Publication Date Title
AT260520B (de) Verfahren zur Herstellung eines Äthylenmischpolymeren
AT260948B (de) Verfahren zur Herstellung neuer, substituierter Hydroxyhydrocarbyloxyalkylsiloxane
AT267483B (de) Verfahren zur Herstellung eines Olefinkohlenwasserstoffes
AT259226B (de) Verfahren zur Herstellung eines Copolymerisates
CH479595A (de) Verfahren zur Herstellung von 1-Peracylglycosyl-5-azacytosinen
CH433275A (de) Verfahren zur Herstellung von 19-Alkylsteroiden
CH458349A (de) Verfahren zur Herstellung eines Isoindolenins
CH468984A (de) Verfahren zur Herstellung von Steroidverbindungen
CH458336A (de) Verfahren zur Herstellung von 3-Keto- 4,5-6,6-spirocyclopropylsteroiden
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
CH491898A (de) Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B,10a-steroids
AT257180B (de) Verfahren zur Herstellung eines Übergangsstückes
CH443288A (de) Verfahren zur Herstellung von Steroid-Galacturoniden
CH444158A (de) Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
CH453353A (de) Verfahren zur Herstellung von 3B-Oxy- 1(10),5-19-nor-steroiden der Androstanreihe
CH423764A (de) Verfahren zur Herstellung von 3-Keto- 4,6-Steroiden
CH433229A (de) Verfahren zur Herstellung von 2-Hydroxy-2,3-dihydrocitral
AT252475B (de) Verfahren zur Herstellung von Pregnan-Derivaten
AT258582B (de) Verfahren zur Herstellung eines Epoxyd-Pfropf-Mischpolymerisates
CH464907A (de) Verfahren zur Herstellung von 19-Hydroxy-4-androsten-3,17-dion
CH460760A (de) Verfahren zur Herstellung eines Pregna-4-en-17-carbonsäure-y-lactons
CH439272A (de) Verfahren zur Herstellung von a, a,-Äthylenketonen
CH433596A (de) Verfahren zur Herstellung eines neuen Antibioticums
AT260430B (de) Verfahren zur Herstellung von 7-Desacetylamino-11,12-dihydrocolchicein
CH438133A (de) Verfahren zur Herstellung eines Bindemittels

Legal Events

Date Code Title Description
PUE Assignment

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V.

PL Patent ceased